Chenqi Lu
Impact in
- Cancer Research top 10%
- Cancer-related molecular mechanisms research
- MicroRNA in disease regulation
- Molecular Biology top 10%
- Protein Degradation and Inhibitors
- Ubiquitin and proteasome pathways
- RNA modifications and cancer
- Pluripotent Stem Cells Research
- CRISPR and Genetic Engineering
Papers in
-
- Cancer-related molecular mechanisms research 7
- MicroRNA in disease regulation 7
-
- CRISPR and Genetic Engineering 4
- Pluripotent Stem Cells Research 4
- Wnt/β-catenin signaling in development and cancer 3
- RNA Research and Splicing 3
- Protein Structure and Dynamics 2
- Cancer-related gene regulation 2
- Co-authors
- Jiuhong Kang (12 shared papers)Xudong Guo (12 shared papers)Guiying Wang (7 shared papers)Dan Ye (3 shared papers)Jianmin Wang (2 shared papers)Qidong Liu (2 shared papers)Guoyan Wang (1 shared paper)Xiaohua Hu (3 shared papers)
- Journals
- Stem Cells (4 papers)PLoS ONE (3 papers)Oncotarget (2 papers)Nature (1 paper)Clinical and Translational Medicine (1 paper)
- Partner nations
- ChinaUnited KingdomUnited States
In The Last Decade
Chenqi Lu
29 papers receiving 1.1k citations
Chenqi Lu's Hit Papers
Peers
Comparison fields: 5 of 92
- Cancer Research 233
- Molecular Biology 782
- Aging 11
- Oncology 122
- Physiology 20
Countries citing papers authored by Chenqi Lu
This map shows the geographic impact of Chenqi Lu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chenqi Lu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chenqi Lu more than expected).
Fields of papers citing papers by Chenqi Lu
This network shows the impact of papers produced by Chenqi Lu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chenqi Lu. The network helps show where Chenqi Lu may publish in the future.
Co-authors
The 25 scholars most cited alongside Chenqi Lu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 29 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Allele-selective lowering of mutant HTT protein by HTT–LC3 linker compounds Hit paper breakdown → | 2019 | 415 |
| 2 | 2013 | 149 | |
| 3 | 2018 | 81 | |
| 4 | 2007 | 62 | |
| 5 | 2013 | 37 | |
| 6 | 2017 | 34 | |
| 7 | RNAi-mediated silencing of NOX4 inhibited the invasion of gastric cancer cells through JAK2/STAT3 signaling. | 2017 | 32 |
| 8 | 2008 | 30 | |
| 9 | 2017 | 28 | |
| 10 | 2012 | 24 | |
| 11 | 2012 | 24 | |
| 12 | 2024 | 23 | |
| 13 | 2021 | 20 | |
| 14 | 2020 | 19 | |
| 15 | 2007 | 19 | |
| 16 | 2017 | 18 | |
| 17 | 2017 | 13 | |
| 18 | 2020 | 11 | |
| 19 | 2019 | 11 | |
| 20 | 2010 | 11 |
About Chenqi Lu
Chenqi Lu is a scholar working on Cancer Research, Molecular Biology, Reproductive Medicine, Immunology and Oncology, having authored 29 papers that have together received 1.1k indexed citations. Recurring topics across this work include Cancer-related molecular mechanisms research (7 papers), MicroRNA in disease regulation (7 papers), CRISPR and Genetic Engineering (4 papers), Pluripotent Stem Cells Research (4 papers), Wnt/β-catenin signaling in development and cancer (3 papers), RNA Research and Splicing (3 papers), Protein Structure and Dynamics (2 papers) and Cancer-related gene regulation (2 papers). The work is most often cited by research in Cancer Research (233 citations), Molecular Biology (782 citations), Aging (11 citations), Oncology (122 citations) and Physiology (20 citations). Chenqi Lu has collaborated with scholars based in China, United Kingdom and United States. Frequent co-authors include Jiuhong Kang, Xudong Guo, Guiying Wang, Dan Ye, Jianmin Wang, Qidong Liu, Guoyan Wang, Xiaohua Hu, Xiheng Hu and Zhi Luo. Their work appears in journals such as Stem Cells, PLoS ONE, Oncotarget, Nature and Clinical and Translational Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.